| Abstrakt: |
This article provides an overview of alcohol use disorder (alcoholism) in the United States and the need for effective treatments. It highlights the high number of deaths related to excessive alcohol use, surpassing deaths from opioids and other substances combined. The article emphasizes that alcohol use disorder is often undertreated, with less than 10% of people receiving any treatment and less than 3% receiving medications. It discusses ongoing research on potential future treatments, such as psychedelic compounds and GLP-1 agonists. The article also provides information on the three FDA-approved medications for alcohol use disorder and mentions other off-label medications. It acknowledges that the effects of these medications on alcohol consumption vary between patients and advises individuals to seek evidence-based treatments for better outcomes. [Extracted from the article] |
